News and events

Press releases

Nicox Announces Last Patient Completes the NCX 470 Denali Phase 3 Clinical Trial

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representative

Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 Clinical Trials in Japan

Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial

Nicox Provides Full Year 2024 Financial Results

Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial

Older press releases

Events and conferences

Videos